Biote (BTMD) Change in Accured Expenses (2021 - 2026)

Biote's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $256000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 109.61% year-over-year to $256000.0; the TTM figure through Mar 2026 stood at $178000.0 (down 94.34% YoY), while the FY2025 annual figure was -$2.7 million, down 159.22% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $256000.0, up from -$1.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $4.9 million in Q3 2023, with the low at -$26.1 million in Q2 2022.
• The 5-year median for Change in Accured Expenses is -$826000.0 (2023), against an average of -$1.6 million.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses tumbled 32986.68% in 2022, then surged 358.59% in 2024.
• Biote's Change in Accured Expenses stood at $555000.0 in 2022, then sank by 421.08% to -$1.8 million in 2023, then soared by 358.59% to $4.6 million in 2024, then slumped by 127.6% to -$1.3 million in 2025, then soared by 120.13% to $256000.0 in 2026.
• Business Quant data shows BTMD's Change in Accured Expenses at $256000.0 in Q1 2026, -$1.3 million in Q4 2025, and $2.4 million in Q3 2025.